EuroPCR 2026 | Does calcium morphology define the choice between IVL and cutting balloon?

The treatment of calcified coronary lesions remains one of the most technically challenging scenarios in contemporary angioplasty. In this context, intravascular lithotripsy (IVL) and cutting balloon (CB) represent two widely used plaque-modifying strategies. The relative efficacy of both techniques may depend not only on calcium severity, but also on its morphology and the concomitant use of atherectomy.

The IVUS substudy of the ShortCUT Trial evaluated whether the performance of cutting balloon versus IVL remained consistent across different patterns of coronary calcification. The study included 413 patients with calcified coronary artery disease undergoing IVUS-guided PCI. Patients were stratified according to the initial plan for rotational atherectomy: 208 patients with planned atherectomy and 205 without planned atherectomy. Within each stratum, patients were randomized 1:1 to CB or IVL, followed by DES implantation. The primary endpoint was postprocedural minimum stent area (MSA) at the site of maximal calcification. Secondary endpoints included calcium fracture, stent expansion percentage, and procedural cost.

In the nodular calcium analysis, no significant differences were observed in the overall cohort between IVL and CB regarding MSA: 8.2 ± 2.1 mm² vs 9.2 ± 2.6 mm², respectively (p=0.25). There were also no differences in stent expansion or calcium fracture. However, procedural cost was significantly higher with IVL (USD 18,833 vs USD 10,958; p<0.001). In the subgroup without planned atherectomy, IVL was associated with greater MSA in nodular calcium lesions: 9.6 ± 3.0 mm² vs 7.6 ± 1.5 mm² (p=0.04).

Read also: TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI.

Regarding the analysis according to calcium arc, in the 360° calcium arc cohort, IVL demonstrated greater MSA compared with CB: 8.6 ± 2.4 mm² vs 7.8 ± 2.3 mm² (p=0.007), with an even more pronounced difference in patients without planned rotational atherectomy (8.9 ± 2.2 mm² vs 7.4 ± 1.8 mm²; p=0.001). Conversely, in lesions with calcium arc <360°, no significant differences were observed in MSA, stent expansion, or calcium fracture in the overall cohort, although procedural cost remained consistently higher with IVL across all analyses.

In patients treated with upfront rotational atherectomy, differences between IVL and cutting balloon were less evident. The “Rota-Cut” strategy showed comparable results to “Rota-Shock” across the different morphologies analyzed, with lower procedural cost.

Conclusion: IVL showed advantages in complex calcium without prior atherectomy

In this IVUS substudy of the ShortCUT Trial, the choice between IVL and cutting balloon appears to depend on the pattern of calcification and the use of rotational atherectomy. In more complex calcium lesions, such as 360° arc or nodular calcium, IVL achieved greater MSA in patients without planned atherectomy. In contrast, after upfront rotational atherectomy, the addition of CB provided results comparable to IVL with lower procedural cost.

Original Title: Subestudio IVUS del ShortCUT Trial.

Reference: Presentado por Suzanne J. Baron en Late-breaking trials, EuroPCR 2026, 19-22 de mayo de 2026, París, Francia. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...